19 June 2013
Keywords: Recordati, OTC portfolio, Russia, Akvion
Article | 16 October 2012
Italian drugmaker Recordati (RC: MI) yesterday announced the signing of agreements covering the acquisition of all rights to five product ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 October 2012
17 October 2012
18 June 2013
© 2013 thepharmaletter.com